Wolfgang Schreiner

9PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targetsCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 21, 2023
Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy.

Michael Kenn, Rudolf Karch, Christian F Singer

|Apr 23, 2022
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer.

Michael Kenn, Rudolf Karch, Dan Cacsire Castillo-Tong

|Nov 30, 2021
Galectin network in osteoarthritis: galectin-4 programs a pathogenic signature of gene and effector expression in human chondrocytes in vitro.

Katharina M Pichler, Anita Fischer, Jürgen Alphonsus

|Dec 30, 2020
Pembrolizumab Induces an Unexpected Conformational Change in the CC'-loop of PD-1.

Bernhard Roither, Chris Oostenbrink, Georg Pfeiler

|Dec 29, 2020
Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357.

Elisabeth S Gruber, Georg Oberhuber, Peter Birner

|Dec 14, 2020
Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab.

Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner

Pageof 2

Frequent Collaborators

3 joint publications

Rudolf Karch

2 joint publications

Christian F Singer

2 joint publications

Heinz Koelbl

1 joint publications

Michael Cibena